Happy to join the JCO Precision Oncology Conversations podcast https://t.co/hlh7YjfpWG to discuss our recent publication https://t.co/g1NPF8IJS5. @JCOPO_ASCO @thenasheffect
Transcriptomic Profiling of Primary Prostate Cancers and Nonlocalized Disease on Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography: A Multicenter Retrospective Study.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jul 2024 – Oct 2024Where it's discussed
-
X / Twitter19 posts
-
YouTube1 videos
AI synopsis
What people are saying
The discussions demonstrate high interest and engagement, with posts praising the study’s findings, such as mentions of the link between genomic scores and nonlocalized prostate cancer, and emphasizing the potential clinical implications. The tone is supportive and focused on advancing understanding, reflecting a recognition of the study's influence on future research and treatment strategies.
Most discussions support the findings, highlighting the link between genetic scores and disease visualization, with some posts explicitly endorsing the study's conclusions.
Posts express high interest, referencing the publication, its methods, and implications for prostate cancer management, showing active engagement.
Many comments cite specific details such as Decipher scores and PSMA PET/CT results, indicating deep engagement with the study's methodology and significance.
While the discussions are favorable and show recognition of the study’s importance, they are mostly informative and promotional, implying a moderate impact on the field and audiences.
Abstract in brief
- The study aimed to explore the link between Decipher genomic classifier scores and metastatic spread as evidenced by PSMA PET/CT scans in prostate cancer patients.
- Data from 586 patients (329 pretreatment, 257 post-radical prostatectomy) showed that higher Decipher scores correlated with a higher likelihood of nonlocalized disease, indicating worse outcomes.
- Results indicated distinct differences in genetic profiles between localized and nonlocalized disease, with nonlocalized cases showing more mutations and specific transcriptomic signatures related to metabolism and androgen receptor signaling.
Top posts
Most liked on X and BlueskyTranscriptomic Profiling of Primary Prostate Cancers and Nonlocalized Disease on Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography: A Multicenter Retrospective Study | JCO Precision Oncology https://t.co/5TGrxRFMmG
Congratulations to our alumni @krkksub, fellow @AndresRicaurte1, chief @JOsbMD and co-authors for their latest paper published in @JCOPO_ASCO on the relationship between decipher scores and PSMA PET. @HimanshuNagarMD @Chris_Barbieri1 @WCMRadiology @UCLA https://t.co/v2bSPhjQQj
Transcriptomic Profiling of Primary Prostate Cancers and Nonlocalized Disease on Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography: A Multicenter Retrospective Study: https://t.co/OpTvlhM77F @amarukishan #pcsm
A new study of 568 patients linked higher Decipher Prostate genomic scores with non-localized #ProstateCancer seen on PSMA PET/CT scans, both pre- and post-treatment. Read more in the full publication here: https://t.co/vP8HYa3jw6 https://t.co/69wtExJLDp
All mentions
Transcriptomic Analysis of Primary and Nonlocalized Prostate Cancer
Dr. Kishan discusses the link between Decipher genomic scores and metastatic spread in prostate cancer, based on a multicenter study of 586 patients, highlighting genetic differences between localized and nonlocalized…
RT @AmarUKishan: Happy to join the JCO Precision Oncology Conversations podcast https://t.co/hlh7YjfpWG to discuss our recent publication h…
RT @AmarUKishan: Happy to join the JCO Precision Oncology Conversations podcast https://t.co/hlh7YjfpWG to discuss our recent publication h…
Happy to join the JCO Precision Oncology Conversations podcast https://t.co/hlh7YjfpWG to discuss our recent publication https://t.co/g1NPF8IJS5. @JCOPO_ASCO @thenasheffect
RT @JCOPO_ASCO: Transcriptomic Profiling of Primary Prostate Cancers and Nonlocalized Disease on Prostate-Specific Membrane Antigen Positr…
RT @WCMRadiology:
RT @WCMRadiology:
RT @Decipher_VCYT: A new study of 568 patients linked higher Decipher Prostate genomic scores with non-localized #ProstateCancer seen on PS…
A new study of 568 patients linked higher Decipher Prostate genomic scores with non-localized #ProstateCancer seen on PSMA PET/CT scans, both pre- and post-treatment. Read more in the full publication here: https://t.co/vP8HYa3jw6 https://t.co/69wtExJLDp
RT @JCOPO_ASCO: Transcriptomic Profiling of Primary Prostate Cancers and Nonlocalized Disease on Prostate-Specific Membrane Antigen Positr…
Transcriptomic Profiling of Primary Prostate Cancers and Nonlocalized Disease on Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography: A Multicenter Retrospective Study: https://t.co/OpTvlhM77F @amarukishan #pcsm
RT @MolecularWCM: Congratulations to our alumni @krkksub, fellow @AndresRicaurte1, chief @JOsbMD and co-authors for their latest paper publ…
RT @MolecularWCM: Congratulations to our alumni @krkksub, fellow @AndresRicaurte1, chief @JOsbMD and co-authors for their latest paper publ…
RT @MolecularWCM: Congratulations to our alumni @krkksub, fellow @AndresRicaurte1, chief @JOsbMD and co-authors for their latest paper publ…
RT @MolecularWCM: Congratulations to our alumni @krkksub, fellow @AndresRicaurte1, chief @JOsbMD and co-authors for their latest paper publ…
RT @MolecularWCM: Congratulations to our alumni @krkksub, fellow @AndresRicaurte1, chief @JOsbMD and co-authors for their latest paper publ…
Congratulations to our alumni @krkksub, fellow @AndresRicaurte1, chief @JOsbMD and co-authors for their latest paper published in @JCOPO_ASCO on the relationship between decipher scores and PSMA PET. @HimanshuNagarMD @Chris_Barbieri1 @WCMRadiology @UCLA https://t.co/v2bSPhjQQj
RT @Davicioni: Transcriptomic Profiling of Primary Prostate Cancers and Nonlocalized Disease on Prostate-Specific Membrane Antigen Positron…
Transcriptomic Profiling of Primary Prostate Cancers and Nonlocalized Disease on Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography: A Multicenter Retrospective Study | JCO Precision Oncology https://t.co/5TGrxRFMmG